Dana-Farber Cancer Institute

https://www.dana-farber.org/

 

Dana-Farber Cancer Institute
A

CAR T-Cells in Multiple Myeloma in 2024

By Dana-Farber Cancer Institute FEATURING Adam Sperling
By Dana-Farber Cancer Institute FEATURING Adam Sperling
282 views
July 2, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss
Multiple Myeloma Patient Symposium
26:56

Updates on AL Amyloidosis Treatment: What’s New in 2024

Dana-Farber Cancer Institute

G. Bianchi

195 views
18:51

Multiple Myeloma 101: Diagnosis, Prognosis, and Risk

Dana-Farber Cancer Institute

P. Richardson

764 views
22:45

CAR T-Cells in Multiple Myeloma in 2024

Dana-Farber Cancer Institute

A. Sperling

282 views
19:35

Updates in the Management of SMM/MGUS and the Prevention of Progress…

Dana-Farber Cancer Institute

Y. Liu

94 views
28:37

Bispecific Antibody Therapy in Multiple Myeloma

Dana-Farber Cancer Institute

S. Midha

76 views
35:27

Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

727 views
24:16

Future of Novel Next Generation Therapy in the Management of R/R MM

Dana-Farber Cancer Institute

P. Richardson

232 views
35:50

Continued Evolution of Therapy for Patients With Newly Diagnosed MM

Dana-Farber Cancer Institute

C. Mo

146 views